P/E is lower than all competitors, earnings are great, innovation is superior, management top shelf,
What's to worry about?
Bummer was involved in gun running. His buddy was AG, so you know the rest.
Ollie North involved in Iran Contra to keep the Americas free of communism. Remember, we had a president then who hated communism, unlike the libs of today.
If Killery is elected, it will be déjà vu once again. It will emulate the debackle she initiated in 1993 when her husband was elected and chose her to change America's healthcare system. I worked for BMS and we immediately cut two of five sales forces and cut our R&D in half. It took them years to recover while innovation suffered, and not just at Bristol, but throughout the industry.
It's the liberal concept of money, investment, and innovation that is not well understood.
Now now Murph, settle down. Opinions basically are just like #$%$, everyone has one, but some stink more than others. Nobody can accurately forecast for certain what the future holds, especially in biotech. But I do know for sure, a P/E of 7 for this company is absurd.
Cruz understands innovation and free enterprise.
Trump will come to his senses with prodding.
Killery and Bernie are hopeless fools!
Pharma now represents 12 percent of all healthcare dollars. Best bang for the buck by far.
What entity is more responsible for us living 20 years longer than our grandparents.
Innovation is not cheap. In 1993 I worked for BMS when Killery tried to destroy Pharma, and we went from 5 sales forces to 3. R&D was cut in half just like most pharma companies. It set drug innovation back years. Hopefully, saner heads will prevail this election and post election.
If I had your confidence in Merck and other pharma companies, don't think I'd have any in my investing portfolio. Go to oil stocks, gold, treasury notes for a great return.
Boat anchors don't have 25 billion in the bank, P/E's of 7, great R&D, great leadership, and unlimited potential. Try another company that may fit your image?
When Trump is elected, he will have many other issues to be concerned with, the least of which will be drug pricing. He's a businessman, and when he sees that Gild meds save healthcare dollars, which are not infinite, he will embrace the company pricing.
The politicians never figured out that an excessive tax rate for corps is not conducive to more innovation, more defined planning for their future. This Congress had a chance for real change and blew it.
No wonder the outside candidates are doing well.